Debrecen, Hungary

Berta Mako

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszerarugyar Rt. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Berta Mako. Retrieved from https://idiyas.com/inventor/berta-mako

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Berta Mako: Innovator in Cyclosporin A Purification

Introduction

Berta Mako is a distinguished inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceutical sciences, particularly in the purification of cyclosporin A, a crucial compound in immunosuppressive therapy.

Latest Patents

Berta Mako holds a patent for a process titled "Process for the purification of cyclosporin A." This innovative method involves the solution chromatographic purification of cyclosporin A from a mixture containing various cyclosporin components and contaminants. The process includes heating the starting mixture to a temperature between 80°C and 115°C, melting it, and then performing solution chromatography using specific solvent mixtures.

Career Highlights

Throughout her career, Berta has demonstrated a commitment to advancing pharmaceutical technologies. Her work at Biogal Gyogyszerarugyar Rt. has positioned her as a key player in the development of effective purification methods for important pharmaceutical compounds.

Collaborations

Berta has collaborated with notable colleagues, including Tibor Szanya and Laszlo Hanak, to further enhance the research and development of innovative pharmaceutical processes.

Conclusion

Berta Mako's contributions to the purification of cyclosporin A exemplify her dedication to innovation in the pharmaceutical industry. Her work continues to impact the field positively, showcasing the importance of effective purification methods in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…